60 results
6-K
EX-10.2
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
of the Change of Control), an amount equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the effective date … of such Change of Control, the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
to such event. In certain circumstances, the holder will have the right to receive the Black Scholes Value of the warrant calculated pursuant
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
of labeling statements, such as a “black box” warning or a contraindication;
we, or any of our collaborators, may be required to create a Medication … of the equity or liability instruments issued. The fair value of our share-based compensation grants is computed as of the grant date based on the Black
6-K
EX-99
BLRX
Bioline Rx Ltd
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
.
The fair value of the warrants is computed using the Black-Scholes option pricing model and is determined by using a level 3 valuation technique. The fair
6-K
EX-99
qal5k
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
EX-99
3a432g
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-99
cq8tkvqev
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-99
70lp5etct0zb
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am
6-K
EX-10.2
azmm02q17jy6
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.3
xd6mq1 c0o5r1k16h56q
21 Sep 22
Current report (foreign)
8:00am
424B5
clvw2rhx7mw0nkeh
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
770tbiyt ohzxfvya
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-99
q5w24a rxs5c
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-99
m90te38moan1s7
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-3
ywsla
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
EX-99
f9xhwtj5u
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
bg6sqa 6o1ldkhv66
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
6-K
EX-99
a67 89bv6i124t1kxq
26 Feb 21
Extraordinary General Meeting of Shareholders on
4:30pm